{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:37:43Z","timestamp":1789767463006,"version":"4.0.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.jns.2004.05.008","type":"journal-article","created":{"date-parts":[[2004,7,7]],"date-time":"2004-07-07T14:52:32Z","timestamp":1089211952000},"page":"167-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":141,"title":["Leptomeningeal metastasis: survival and prognostic factors in 155 patients"],"prefix":"10.1016","volume":"223","author":[{"given":"Ulrich","family":"Herrlinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"F\u00f6rschler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelm","family":"K\u00fcker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Meyermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bamberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Dichgans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Weller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2004.05.008_BIB1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF02341153","article-title":"Leptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias","volume":"9","author":"Kaplan","year":"1990","journal-title":"J. Neuro-oncol"},{"key":"10.1016\/j.jns.2004.05.008_BIB2","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1200\/JCO.2000.18.10.2053","article-title":"Treatment of leptomeningeal metastases evaluated by interphase cytogenetics","volume":"18","author":"Van Oostenbrugge","year":"2000","journal-title":"J. Clin. Oncol"},{"key":"10.1016\/j.jns.2004.05.008_BIB3","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1001\/archneur.1996.00550070064013","article-title":"Leptomeningeal carcinomatosis. Presenting features and prognostic factors","volume":"53","author":"Balm","year":"1996","journal-title":"Arch. Neurol"},{"key":"10.1016\/j.jns.2004.05.008_BIB4","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/1097-0142(19910315)67:6<1685::AID-CNCR2820670635>3.0.CO;2-M","article-title":"Meningeal carcinomatosis in breast cancer: prognostic factors and influence of treatment","volume":"67","author":"Boogerd","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.jns.2004.05.008_BIB5","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1315::AID-CNCR14>3.0.CO;2-4","article-title":"Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen","volume":"77","author":"Fizazi","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.jns.2004.05.008_BIB6","first-page":"611","article-title":"Leptomeningeal metastases. Treatment results in 98 consecutive patients","volume":"24","author":"Pfeffer","year":"1988","journal-title":"Isr. J. Med. Sci"},{"key":"10.1016\/j.jns.2004.05.008_BIB7","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7","article-title":"Diagnosis and treatment of leptomeningeal metastases from solid tumors","volume":"49","author":"Wasserstrom","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.jns.2004.05.008_BIB8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1200\/JCO.1992.10.1.143","article-title":"Phase I\/II trial and pharmacokinetics of intrathecal diaziquone in refractory meningeal malignancies","volume":"10","author":"Berg","year":"1992","journal-title":"J. Clin. Oncol"},{"key":"10.1016\/j.jns.2004.05.008_BIB9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1200\/JCO.2003.04.053","article-title":"Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitis","volume":"21","author":"Blaney","year":"2003","journal-title":"J. Clin. Oncol"},{"key":"10.1016\/j.jns.2004.05.008_BIB10","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1002\/cncr.10547","article-title":"A phase II trial of intra-cerebrospinal fluid alpha interferon in the treatment of neoplastic meningitis","volume":"94","author":"Chamberlain","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.jns.2004.05.008_BIB11","first-page":"3394","article-title":"A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors","volume":"5","author":"Glantz","year":"1999","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.jns.2004.05.008_BIB12","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1200\/JCO.1999.17.10.3110","article-title":"Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis","volume":"17","author":"Glantz","year":"1999","journal-title":"J. Clin. Oncol"},{"key":"10.1016\/j.jns.2004.05.008_BIB13","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1200\/JCO.1993.11.3.561","article-title":"Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis","volume":"11","author":"Grossman","year":"1993","journal-title":"J. Clin. Oncol"},{"key":"10.1016\/j.jns.2004.05.008_BIB14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1054\/bjoc.2000.1574","article-title":"Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine","volume":"84","author":"Jaeckle","year":"2001","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jns.2004.05.008_BIB15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1023\/A:1015752331041","article-title":"An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitis","volume":"57","author":"Jaeckle","year":"2002","journal-title":"J. Neuro-oncol"},{"key":"10.1016\/j.jns.2004.05.008_BIB16","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/(SICI)1097-0142(19980501)82:9<1764::AID-CNCR24>3.0.CO;2-1","article-title":"Leptomeningeal metastases from solid tumors: a comparison of two prospective series treated with and without intra-cerebrospinal fluid chemotherapy","volume":"82","author":"Bokstein","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.jns.2004.05.008_BIB17","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1200\/JCO.1998.16.4.1561","article-title":"High-dose intravenous methotrexate for patients with nonleukemic cancer: is intrathecal chemotherapy necessary?","volume":"16","author":"Glantz","year":"1998","journal-title":"J. Clin. Oncol"},{"key":"10.1016\/j.jns.2004.05.008_BIB18","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/archneur.1981.00510110056008","article-title":"Meningeal carcinomatosis","volume":"38","author":"Theodore","year":"1981","journal-title":"Arch. Neurol"},{"key":"10.1016\/j.jns.2004.05.008_BIB19","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/1097-0142(19930715)72:2<439::AID-CNCR2820720220>3.0.CO;2-4","article-title":"The role of systemic high-dose cytarabine in the treatment of central nervous system leukemia","volume":"72","author":"Morra","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.jns.2004.05.008_BIB20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1159\/000116043","article-title":"Diagnosis and treatment of meningeal carcinomatosis in 10 patients with breast cancer","volume":"25","author":"Schabet","year":"1986","journal-title":"Eur. Neurol"},{"key":"10.1016\/j.jns.2004.05.008_BIB21","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/1097-0142(19920315)69:6<1475::AID-CNCR2820690627>3.0.CO;2-D","article-title":"Tumor cell dissemination triggers an intrathecal immune response in neoplastic meningitis","volume":"69","author":"Weller","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.jns.2004.05.008_BIB22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-0404.1992.tb05053.x","article-title":"Humoral CSF parameters in the differential diagnosis of hematologic CNS neoplasia","volume":"86","author":"Weller","year":"1992","journal-title":"Acta Neurol. Scand"},{"key":"10.1016\/j.jns.2004.05.008_BIB23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF01324835","article-title":"Intrathecal IgM response in disseminated cerebrospinal metastasis from malignant melanoma","volume":"16","author":"Weller","year":"1993","journal-title":"J. Neuro-oncol"},{"key":"10.1016\/j.jns.2004.05.008_BIB24","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/1097-0142(20010101)91:1<130::AID-CNCR17>3.0.CO;2-8","article-title":"Primary CNS lymphoma 1991\u20131997: outcome and late adverse effects after combined modality treatment","volume":"91","author":"Herrlinger","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.jns.2004.05.008_BIB25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ana.10102","article-title":"German Cancer Society Neuro-Oncology Working group NOA-03 multi-center trial of single agent high-dose methotrexate for primary CNS lymphoma","volume":"51","author":"Herrlinger","year":"2002","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.jns.2004.05.008_BIB26","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1212\/WNL.54.8.1707","article-title":"PCV salvage chemotherapy for recurrent primary CNS lymphoma","volume":"54","author":"Herrlinger","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2004.05.008_BIB27","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1212\/WNL.58.10.1573","article-title":"First-line therapy with temozolomide induces complete response in primary CNS lymphoma","volume":"58","author":"Herrlinger","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2004.05.008_BIB28","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Non-parametric estimations from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J. Am. Stat. Assoc"},{"key":"10.1016\/j.jns.2004.05.008_BIB29","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1200\/JCO.1992.10.4.635","article-title":"Combined modality therapy for primary CNS lymphoma","volume":"10","author":"DeAngelis","year":"1992","journal-title":"J. Clin. Oncol"},{"key":"10.1016\/j.jns.2004.05.008_BIB30","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/BF01476415","article-title":"Leptomeningeal dissemination of malignant gliomas. Incidence, diagnosis and outcome","volume":"126","author":"Arita","year":"1994","journal-title":"Acta Neurochir"},{"key":"10.1016\/j.jns.2004.05.008_BIB31","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1001\/archneur.1994.00540170033013","article-title":"Clinical outcome in aggressively treated meningeal carcinomatosis","volume":"51","author":"Grant","year":"1994","journal-title":"Arch. Neurol"},{"key":"10.1016\/j.jns.2004.05.008_BIB32","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1200\/JCO.1987.5.10.1655","article-title":"A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis","volume":"5","author":"Hitchins","year":"1987","journal-title":"J. Clin. Oncol"},{"key":"10.1016\/j.jns.2004.05.008_BIB33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1023\/A:1006156204385","article-title":"Intracranial involvement by metastatic advanced gastric carcinoma","volume":"43","author":"Kim","year":"1999","journal-title":"J. Neuro-oncol"},{"key":"10.1016\/j.jns.2004.05.008_BIB34","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1002\/cncr.10554","article-title":"Soft tissue sarcoma brain metastases. Prevalence in a cohort of 3829 patients","volume":"94","author":"Espat","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.jns.2004.05.008_BIB35","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1006\/gyno.1994.1199","article-title":"Case report and review of literature: leptomeningeal relapse in epithelial ovarian cancer","volume":"54","author":"Khalil","year":"1994","journal-title":"Gynecol. Oncol"},{"key":"10.1016\/j.jns.2004.05.008_BIB36","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s00277-002-0475-2","article-title":"Chronic lymphocytic leukemia presenting with symptomatic central nervous system involvement","volume":"81","author":"Akintola-Ogunremi","year":"2002","journal-title":"Ann. Hematol"},{"key":"10.1016\/j.jns.2004.05.008_BIB37","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/10428190210191","article-title":"Leukemic leptomeningeal involvement in stage 0 and stage 1 chronic lymphocytic leukemia","volume":"43","author":"Brick","year":"2002","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.jns.2004.05.008_BIB38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1212\/WNL.46.1.19","article-title":"Chronic lymphocytic leukemia and the central nervous system: a clinical and pathological study","volume":"46","author":"Cramer","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2004.05.008_BIB39","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/(SICI)1097-0142(19960201)77:3<543::AID-CNCR17>3.0.CO;2-4","article-title":"A comparison of polymerase chain reaction examination of cerebrospinal fluid and conventional cytology in the diagnosis of lymphomatous meningitis","volume":"77","author":"Rhodes","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.jns.2004.05.008_BIB40","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/1531-8249(200002)47:2<211::AID-ANA11>3.0.CO;2-9","article-title":"Molecular analysis of the CDR3 encoding region of the immunoglobulin heavy chain locus in cerebrospinal fluid cells as a diagnostic tool in lymphomatous meningitis","volume":"47","author":"Storch-Hagenlocher","year":"2000","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.jns.2004.05.008_BIB41","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ana.410380212","article-title":"Leptomeningeal tumor in primary central nervous system lymphoma: recognition, significance, and implications","volume":"38","author":"Balmaceda","year":"1995","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.jns.2004.05.008_BIB42","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1200\/JCO.1999.17.10.3234","article-title":"Comparison of CSF cytology and spinal magnetic resonance imaging in the detection of leptomeningeal disease in pediatric medulloblastoma or primitive neuroectodermal tumor","volume":"17","author":"Fouladi","year":"1999","journal-title":"J. Clin. Oncol"},{"key":"10.1016\/j.jns.2004.05.008_BIB43","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ana.410380111","article-title":"Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis","volume":"38","author":"Freilich","year":"1995","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.jns.2004.05.008_BIB44","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/00004728-199007000-00008","article-title":"Meningeal Gd-DTPA enhancement in patients with malignancies","volume":"14","author":"Paakko","year":"1990","journal-title":"J. Comput. Assist. Tomogr"},{"key":"10.1016\/j.jns.2004.05.008_BIB45","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1023\/A:1005982826121","article-title":"Radioisotope CSF flow studies in leptomeningeal metastases","volume":"38","author":"Chamberlain","year":"1998","journal-title":"J. Neuro-Oncol"},{"key":"10.1016\/j.jns.2004.05.008_BIB46","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1002\/1097-0142(19941215)74:12<3135::AID-CNCR2820741212>3.0.CO;2-8","article-title":"Carcinomatous meningitis in patients with breast cancer. An aggressive disease variant","volume":"74","author":"Joyson","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.jns.2004.05.008_BIB47","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1212\/WNL.49.6.1728","article-title":"Non-AIDS-related lymphomatous meningitis: combined modality therapy","volume":"49","author":"Chamberlain","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2004.05.008_BIB48","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1001\/archneur.1995.00540330094020","article-title":"Pharmacokinetics of intralumbar DTC101 for the treatment of leptomeningeal metastases","volume":"52","author":"Chamberlain","year":"1995","journal-title":"Arch. Neurol"},{"key":"10.1016\/j.jns.2004.05.008_BIB49","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1212\/WNL.44.8.1463","article-title":"Leptomeningeal metastases: analysis of 31 patients with sustained off-therapy response following combined-modality therapy","volume":"44","author":"Siegal","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2004.05.008_BIB50","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1212\/WNL.35.9.1274","article-title":"Ommaya reservoir in 387 cancer patients: a 15-year experience","volume":"35","author":"Obbens","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2004.05.008_BIB51","first-page":"49","article-title":"Ommaya reservoirs for the treatment of leptomeningeal metastases","volume":"47","author":"Sandberg","year":"2000","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jns.2004.05.008_BIB52","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1200\/JCO.2002.04.140","article-title":"Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases","volume":"20","author":"Antonadou","year":"2002","journal-title":"J. Clin. Oncol"},{"key":"10.1016\/j.jns.2004.05.008_BIB53","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1200\/JCO.1994.12.10.2013","article-title":"Chemotherapy for anaplastic oligodendroglioma","volume":"2","author":"Cairncross","year":"1994","journal-title":"J. Clin. Oncol"},{"key":"10.1016\/j.jns.2004.05.008_BIB54","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF00172603","article-title":"Primary central nervous system lymphoma: a role for adjuvant chemotherapy","volume":"14","author":"Chamberlain","year":"1992","journal-title":"J. Neuro-Oncol"},{"key":"10.1016\/j.jns.2004.05.008_BIB55","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1200\/JCO.1999.17.9.2762","article-title":"Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse","volume":"17","author":"Yung","year":"1999","journal-title":"J. Clin. Oncol"},{"key":"10.1016\/j.jns.2004.05.008_BIB56","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJM200108233450817","article-title":"Treatment of brain metastases of malignant melanoma with temozolomide","volume":"345","author":"Biasco","year":"2001","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.jns.2004.05.008_BIB57","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00008390-200204000-00011","article-title":"Effect of temozolomide on central nervous system relapse in patients with advanced melanoma","volume":"12","author":"Paul","year":"2002","journal-title":"Melanoma Res"},{"key":"10.1016\/j.jns.2004.05.008_BIB58","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF00148388","article-title":"Combined intraommaya methotrexate, cytosine arabinoside, hydrocortisone and thiotepa for meningeal involvement by malignancies","volume":"5","author":"Stewart","year":"1987","journal-title":"J. Neuro-Oncol"},{"key":"10.1016\/j.jns.2004.05.008_BIB59","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1002\/cncr.11449","article-title":"Quality-of-life-adjusted survival comparison of sustained-release cytosine arabinoside versus intrathecal methotrexate for treatment of solid tumor neoplastic meningitis","volume":"97","author":"Cole","year":"2003","journal-title":"Cancer"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X04001674?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X04001674?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:38:04Z","timestamp":1758382684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X04001674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0022510X04001674"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2004.05.008","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leptomeningeal metastasis: survival and prognostic factors in 155 patients","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2004.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}